Anastasia Zaytseva

Ms. Anastasia Zaytseva

Almazov National Medical and Research Centre
+1

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
AKAleksandr Khudiakov
Aleksandr Khudiakov
Anastasia ZaytsevaAnastasia Zaytseva
Anastasia Zaytseva
KPKseniya Perepelina
Kseniya Perepelina
NSNatalia Smolina
Natalia Smolina
TPTatiana Pervunina
Tatiana Pervunina
AKAnna Kostareva
Anna Kostareva

25 July 2020 in Cellular Physiology and Biochemistry
Verified
Journal Article
Closed access
PDF file
KGKonstantin Gusev
Konstantin Gusev
AKAleksandr Khudiakov
Aleksandr Khudiakov
Anastasia ZaytsevaAnastasia Zaytseva
Anastasia Zaytseva
KPKseniya Perepelina
Kseniya Perepelina
SMSofia Makeenok
Sofia Makeenok
AKAnna Kostareva
Anna Kostareva
Mutations of desmosomal genes are known to cause arrhythmogenic cardiomyopathy characterized by arrhythmias and sudden cardiac death. Previously, we described a novel genetic variant H1684R in desmoplakin gene (DSP), associated with a progressive cardiac conduction disease (PCCD). In the present study, we aimed to investigate an effect of the DSP-H1684R genetic variant on the activity of ion channels. We used cardiomyocytes derived from induced pluripotent stem cells (iPSC cardiomyocytes) from a patient with DSP-H1684R genetic variant and from two healthy donors. Immunofluorescent staining and western blot analyses were used to characterize patient-specific cardiomyocytes. By the whole-cell voltage-clamp technique we estimated the activity of voltage-gated sodium, calcium, and potassium channels that are responsible for action potential generation and its shape. Action potentials' parameters were measured using whole-cell current-clamp technique. In patient-specific cardiomyocytes we observed both lower amplitudes of currents through sodium Nav1.5 channels and L-type calcium channels, but higher amplitude of current through transient-outward potassium channels in comparison to donor cardiomyocytes. Current-clamp measurements revealed shortening of action-potential in DSP-H1684R-carrying iPSC cardiomyocytes. Therefore, observed alterations in the channels activity might have a great impact on the properties of action potential and development of PCCD. Our results show that desmoplakin genetic variants, besides conduction slowing caused by structural heart remodeling, could affect multiple ion channel activity aggravating arrhythmia manifestation in PCCD.

Verified
Journal Article
Open access
PDF file
Nataliia V. KatolikovaNataliia V. Katolikova
Nataliia V. Katolikova
AKAleksandr Khudiakov
Aleksandr Khudiakov
DSDaria D. Shafranskaya
Daria D. Shafranskaya
APAndrey Prjibelski
Andrey Prjibelski
AMAlexey Masharskiy
Alexey Masharskiy
Anna MalashichevaAnna Malashicheva
Anna Malashicheva
Elaboration of protocols for differentiation of human pluripotent stem cells to dopamine neurons is an important issue for development of cell replacement therapy for Parkinson’s disease. A number of protocols have been already developed; however, their efficiency and specificity still can be improved. Investigating the role of signaling cascades, important for neurogenesis, can help to solve this problem and to provide a deeper understanding of their role in neuronal development. Notch signaling plays an essential role in development and maintenance of the central nervous system after birth. In our study, we analyzed the effect of Notch activation and inhibition at the early stages of differentiation of human induced pluripotent stem cells to dopaminergic neurons. We found that, during the first seven days of differentiation, the cells were not sensitive to the Notch inhibition. On the contrary, activation of Notch signaling during the same time period led to significant changes and was associated with an increase in expression of genes, specific for caudal parts of the brain, a decrease of expression of genes, specific for forebrain, as well as a decrease of expression of genes, important for the formation of axons and dendrites and microtubule stabilizing proteins.

1 March 2024 in Pflügers Archiv - European Journal of Physiology
Verified
Journal Article
Closed access
PDF file
Anastasia ZaytsevaAnastasia Zaytseva
Anastasia Zaytseva
OKOlga E. Kulichik
Olga E. Kulichik
AKAnna. A. Kostareva
Anna. A. Kostareva
BZBoris S. Zhorov
Boris S. Zhorov

1 August 2019 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
Anastasia ZaytsevaAnastasia Zaytseva
Anastasia Zaytseva
AKAlexey V. Karpushev
Alexey V. Karpushev
AKArtem Kiselev
Artem Kiselev
EMEvgeny N Mikhaylov
Evgeny N Mikhaylov
DLDlebedev Lebedev
Dlebedev Lebedev
AKAnna A. Kostareva
Anna A. Kostareva

22 July 2022 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
KPKseniya Perepelina
Kseniya Perepelina
Anastasia ZaytsevaAnastasia Zaytseva
Anastasia Zaytseva
AKAleksandr Khudiakov
Aleksandr Khudiakov
INIrina Neganova
Irina Neganova
EVElena Vasichkina
Elena Vasichkina
AKAnna Kostareva
Anna Kostareva
Pathogenic variants in the LMNA gene are known to cause laminopathies, a broad range of disorders with different clinical phenotypes. LMNA genetic variants lead to tissue-specific pathologies affecting various tissues and organs. Common manifestations of laminopathies include cardiovascular system abnormalities, in particular, cardiomyopathies and conduction disorders. In the present study, we used induced pluripotent stem cells from a patient carrying LMNA p.R249Q genetic variant to create an in vitro cardiac model of laminopathy. Induced pluripotent stem cell-derived cardiomyocytes with LMNA p.R249Q genetic variant showed a decreased sodium current density and an impaired sodium current kinetics alongside with changes in transcription levels of cardiac-specific genes. Thus, we obtained compelling in vitro evidence of an association between LMNA p.R249Q genetic variant and cardiac-related abnormalities.